UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_________________
FORM 8-K
_________________
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): October 7, 2004
_________________
MICROTEK MEDICAL HOLDINGS, INC.
(Exact name of registrant as specified in its charter)
_________________
| Georgia | 0-24866 | 58-1746149 |
(State or Other Jurisdiction
of Incorporation) | (Commission File Number) | (IRS Employer
Identification No.) |
512 Lehmberg Road, Columbus, Mississippi 39702
(Address of principal executive office) (zip code)
Registrant’s telephone number, including area code:(662) 327-1863
(Former name or former address, if changed since last report)
_________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
| Item 2.02 | | Results of Operations and Financial Condition. |
| | On October 7, 2004, Microtek Medical Holdings, Inc. (the “Company”) issued a press release announcing its anticipated net revenues for the quarter ended September 30, 2004. This press release is attached as Exhibit 99.1 to this report and is incorporated herein by reference. |
| Item 9.01 | | Financial Statements and Exhibits. |
| | | (a) | | Financial Statements. |
| | | (b) | | Pro Forma Financial Information. |
| Exhibit Number | Description |
|---|
| | | |
| 99.1 | Press release dated October 7, 2004, announcing the Company's
anticipated net revenues for the quarter ended September 30, 2004 |
| | |
-2-
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | MICROTEK MEDICAL HOLDINGS, INC. |
| | |
| Date: October 7, 2004 | By:/s/ Dan R. Lee |
| | Dan R. Lee, Chairman, President and Chief Executive Officer |
| | |
| | By:/s/ Roger G. Wilson |
| | Roger G. Wilson, Chief Financial Officer |
-3-
EXHIBIT INDEX
| Exhibit Number | Description |
|---|
| | |
| 99.1 | Press release dated October 7, 2004, announcing the Company's anticipated net revenues for the quarter ended September 30, 2004 |
-4-
